Form 8-K - Current report:
SEC Accession No. 0001193125-25-139517
Filing Date
2025-06-12
Accepted
2025-06-12 06:05:29
Documents
18
Period of Report
2025-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828604d8k.htm   iXBRL 8-K 38290
2 EX-1.1 d828604dex11.htm EX-1.1 242981
3 EX-4.1 d828604dex41.htm EX-4.1 63096
4 EX-4.2 d828604dex42.htm EX-4.2 76808
5 EX-5.1 d828604dex51.htm EX-5.1 11053
6 EX-99.1 d828604dex991.htm EX-99.1 10751
10 GRAPHIC g828604g0611224604895.jpg GRAPHIC 3634
  Complete submission text file 0001193125-25-139517.txt   683174

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA caba-20250611.xsd EX-101.SCH 2865
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20250611_lab.xml EX-101.LAB 17994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20250611_pre.xml EX-101.PRE 11271
20 EXTRACTED XBRL INSTANCE DOCUMENT d828604d8k_htm.xml XML 3637
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: AZ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 251041600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)